Restoring satisfactory status in ThinPrep Pap test specimens with too few squamous cells and containing microscopic red blood cells by Pang, Yijun et al.
Restoring Satisfactory Status in
ThinPrep Pap Test Specimens
With Too Few Squamous Cells
and Containing Microscopic Red
Blood Cells
Yijun Pang, M.D., Ph.D.,* Brian Smola, C.T., Robert T. Pu, M.D., Ph.D.,
and Claire W. Michael, M.D.
Treatment of specimens that contain excessive blood can effec-
tively reduce the unsatisfactory rate; however, a considerable
number of unsatisfactory specimens remain. We evaluated the
effectiveness of reprocessing unsatisfactory specimens that had
too few squamous cells and contained microscopic red blood
cells (TFSQRBC).
Out of the 688 unsatisfactory specimens at microscopic
screening, 197 (28.63%) were TFSQRBC that were reprocessed
by treatment of glacial acetic acid (GAA). Red blood cells were
observed clogging the pores in the filter of the ThinPrep device.
After reprocessing, 129 (68.48%) yielded a satisfactory diagno-
sis, which accounted for a reduction of the unsatisfactory rate
by 18.25%. In the restored satisfactory specimens, abnormal
diagnoses of 1 high-grade squamous intraepithelial lesion
(HSIL) (0.78%), 3 atypical glandular cells (AGC) (2.33%), and
13 atypical squamous cells of undetermined significance
(ASCUS) (10.08%) were made. The abnormal diagnoses in this
group of patients were significantly higher than that in the gen-
eral population screened.
Reprocessing unsatisfactory ThinPrep1 (TP) specimens of
TFSQRBC can reduce the unsatisfactory rate of the TP Pap test
significantly and is a cost-effective measure. The initially unsat-
isfactory specimens are more likely to represent cases with an
abnormal diagnosis, which also justifies the effort of reprocess-
ing this group of specimens. Adjustment of the pore size on the
ThinPrep filter device may reduce the interference of red blood
cells.Diagn. Cytopathol. 2008;36:696–700. ' 2008Wiley-Liss, Inc.
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Unsatisfactory specimens exist in both conventional Pap
smears and liquid-based Pap tests. ThinPrep1 (TP) (Cytyc
Corp., Marlborough, MA) is one of the liquid-based cervical
cytology processing techniques. The unsatisfactory rate with
TP ranges from 0.3% to 8.3% at various institutions.1–7
Compared with conventional Pap smears (CP), the fre-
quency of unsatisfactory specimens with TP might be either
more or less.1–5 The split specimen studies demonstrated an
overall increase of unsatisfactory specimens with TP.8
The 2001 Bethesda criteria define that an adequate liq-
uid-based preparation (LBP) should have an estimated
minimum of 5000 well-visualized/well-preserved squa-
mous cells. The most frequent causes of unsatisfactory
status in TP specimens are too few squamous cells, fol-
lowed by obscuration of red blood cells, white blood
cells, and mucin.9–15 Because TP is a filter-based process-
ing technique, non-squamous cell particles, such as white
and red blood cells (RBC) and mucin, compete with squa-
mous cells to adhere on the filter, which results in too
few squamous cells on the slide. Pretreatment of speci-
mens containing grossly visible blood with glacial acetic
acid (GAA) is effective in reducing the unsatisfactory
rate.9,11,12,14,15 However, a subgroup of unsatisfactory
specimen with too few squamous cells was identified with
presence of microscopic red blood cells (TFSQRBC). In
this study, we evaluated the effectiveness of reprocessing
unsatisfactory TP specimens of TFSQRBC and the fol-
low-up outcomes of these patients.
Materials and Methods
Subjects
A total of 45,418 consecutive TP specimens in the
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2006 were studied, including patients seen at the Univer-
sity of Michigan Health Care system, and community hos-
pitals and clinics in the vicinity of Ann Arbor, Michigan.
TP specimens were obtained by the clinicians and submit-
ted to the Department of Pathology. College students
were a noticeable portion in the population studied.
Specimen Preparation
The specimens were collected in PreservCyt1 (Cytyc,
MA). Before processing, the specimens were visually
inspected. Those containing grossly visible blood were
pretreated with GAA according the methods previously
reported.13 ThinPrep slides of all specimens including the
pretreated ones were prepared on a TP 30001 (Cytyc,
MA).
Identification of Unsatisfactory Specimens
and Reprocessing
Upon microscopic screening, the specimens were identi-
fied for reprocessing based on the following criteria: (1)
unsatisfactory due to too few squamous cells and (2) the
presence of intact red blood cells. The Bethesda System
2001 was used for the definition of satisfactory. To deter-
mine the unsatisfactory status, squamous cells were
counted in 10–20 fields under 3400 magnification across
two diameters of the slide. An average less than 3 cells
per field is considered to be too few squamous cells. The
presence of any number of intact red blood cells was con-
sidered to fulfill the second criteria for the specimen to be
reprocessed. The remaining portion of identified speci-
mens was centrifuged at 2,500g for 5 min and the super-
natant was discarded. The cells were resuspended with
gentle vortex in Cytolyt1 that contained 10% GAA. One
additional TP slide was made from the reprocessed speci-
men. The additional slide and the original slide were
rescreened under microscopy for a diagnosis.
Observation of RBC in the ThinPrep Device Filter
The process was interrupted immediately before the cells
were delivered to glass slides. The filter with the collected
cells was taken off, fixed in 95% ethanol, and processed
with Pap stain. Then the filter was adhered on a glass
slide and coversliped with mount gel.
Data Analysis
Patients’ age, referring physician, information of last men-
strual period, and outcome of the reprocessed Pap test
were collected. Fisher’s test were performed to test the
significance of the reprocessing efforts and to identify fac-
tors potentially causing the unsatisfactory diagnosis. Two-
tailed P-values were calculated to assess the statistical
significance. The P-value < 0.05 was considered to be
statistically significant.
Results
We identified 688 unsatisfactory specimens by micro-
scopic screening. Among all initially unsatisfactory speci-
mens, 197 (28.63%) cases met the criteria for reprocess-
ing. Grossly, no visible blood was present in those speci-
mens. Hence, they had not been pretreated (Fig. C-1).
After reprocessing, red blood cells were lysed and the
number of squamous cells and endocervical cells
increased (Fig. C-2). A satisfactory status was restored in
129 (65.48%) specimens. Restored satisfactory status in
the reprocessed specimens resulted in the current unsatis-
factory rate of 1.23%, a reduction of 18.25% from that of
1.51%, if the reprocessing had not been conducted. The
decrease is statistically significant (P < 0.001).
Abnormal diagnoses were made on 17 (13.18%) speci-
mens of restored adequacy with a distribution of 1
(0.78%) high-grade squamous intraepithelial lesion
(HSIL) (Fig. C-3), 3 (2.33%) atypical glandular cells
(AGC), and 13 (10.08%) atypical squamous cells of unde-
termined significance (ASCUS). Comparison of abnormal
findings between the reprocessed group and the general
population screened is presented in Table I. The abnormal
specimens exist more frequently in the reprocessed group
(10.08%) than that in the general population screened in
the year 2005–2006 (6.91%) (P ¼ 0.0088). The diagnoses
Fig. C-1. Hypocellular specimen containing microscopic red blood cells
is not grossly bloody.
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Figs. C-2–C-3. Fig. C-2. A: Hypocellular specimen containing intact red blood cells, 3200. B: Restored cellularity after reprocessing. Debris of lysed
red blood cells present. A negative diagnosis was made based on this specimen, 3200. C: Diagnosis of low grade squamous intraepithelial lesion was
made after reprocessing, 3400. D: Diagnosis of high-grade squamous intraepithelial lesion was made after reprocessing, 3400. Fig. C-3. A: The pores
in the filter were clogged by red blood cells in the ThinPrep specimen. B: Lysed RBC debris in the pores of the filter. C: No interference with the filter
in specimen containing no RBC.
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of ASCUS and AGC are both significantly more frequent
among the specimens with restored satisfactory status
(Table I).
In patients with reprocessed specimens, the age ranged
from 14 to 84 years with a median age of 38 years. To
identify the possible factors that may be significant in
causing unsatisfactory status, we looked into the average
last menstrual period time (LMP), post menopause
status, and possible association with the collector of the
specimen.
We considered patients aged 55 years or older as post
menopausal. Of all the patients with reprocessed speci-
mens, 10.65% (21/197) were post menopausal. Post men-
opausal patients were significantly more frequent in the
group in which unsatisfactory status could not be restored
by reprocessing (17.64%, 12/68), than in the group that
unsatisfactory status was restored (6.98%, 9/129) (Fisher’s
exact test P ¼ 0.028).
The last menstrual period (LMP) information was avail-
able in 119 patients with regular menstrual cycles. The
mean time period from LMP to the specimen collecting
time (SCT) was 9.7 days, and the median was 7 days
with a range of 1–30 days.
The information regarding specimen collectors was
available for 150 reprocessed specimens, associated to
107 clinics. More than 1/3 (66/150) of the reprocessed
specimens were collected in 23 clinics that contributed 2
or more specimens, and one of the clinics had 5 speci-
mens in this group, suggesting that these clinics had
higher tendency to provide suboptimal samples.
Red blood cells in the ThinPrep specimen were
observed clogging the pores of the ThinPrep device filter.
The clogging was reduced in a processed specimen and
debris of red blood cells was present in the pores of the
filter. No clogging was observed in specimen containing
no red blood cells (Fig. C-3).
Discussion
TFSQRBC is a subgroup of specimens that are initially
unsatisfactory and would have not been pretreated with
GAA, because the RBC was not grossly visible. During
the time period of this study, all the pretreated specimens
(n ¼ 254) were satisfactory. The TFSQRBC accounted
for more than a quarter (28.63%) of all unsatisfactory
specimens. The rate of restored satisfactory status
(65.48%) in this specific group was similar to that in the
reprocessed unsatisfactory specimens with gross blood as
previously reported. The reduction (18.25%) of the unsat-
isfactory rate was significant. It is evident that the pres-
ence of red blood cells, even only microscopic, can be a
significant factor to cause unsatisfactory TP preparations.
Recognizing and reprocessing this group of unsatisfactory
specimens with GAA is an effective procedure to reduce
the unsatisfactory rate. It has been reported that up to
26% of the patients with an unsatisfactory Pap test speci-
men have an abnormal follow-up diagnosis.16 A repeat
Pap test is required for patients with an unsatisfactory
specimen, which demand additional clinic visits. Even
worse, many of the patients may be lost in follow ups
and miss the opportunity for prompt detection and inter-
vention of a cervical lesion.11,16 Our study showed that
the frequency of abnormal findings is significantly higher
in patients with an unsatisfactory Pap specimen than that
of the overall screened population (Table I). The efforts
to restore the satisfactory status of this group of speci-
mens are justified. Although reprocessing these unsatisfac-
tory specimens may increase cost at 160%,11 comparing
the increase in reprocessing cost to the cost if the patient
had gone back to the clinic for a repeat Pap test speci-
men, reprocessing this subgroup of specimens is a finan-
cially efficient measure. Most significantly, the integrity
of the Pap test efficiency was restored and the patients
retained the opportunity to be tested properly.
Among the factors that associated or contributing to the
unsatisfactory status of ThinPrep specimen were found
that the SCT relating to menstrual period is significant.
The median SCT was 7 days post LMP indicating that the
majority of these specimens were collected within 7 days
of the LMP. Previous studies suggested that specimens
collected mid-cycle of the menstrual period are optimal
for both cytology and HPV tests and the specimens col-
lected in day 4 to 6 of LMP were most frequently unsatis-
factory.17,18 This finding should catch the attention of cli-
nician colleagues. It is encouraged that the collection of a
Pap test specimen should be at a time close to the middle
of the menstrual cycle. Post menopausal status was signif-
icant, because atrophy of squamous mucosa is frequent.
Consequently, less squamous cells are obtained in the
specimen because the squamous epithelium is thinner and
the squamous cells are smaller and more cohesive. It is
also true that the tendency of bleeding exists when the
atrophic cervices are sampled for Pap test. These state-
ments are supported by our data that the Pap test speci-
mens of post menopausal patients are more likely to
remain unsatisfactory after being reprocessed. Correcting
the atrophy by topical estrogen therapy is recommended
for this group of patients before a repeat Pap test.
Although the Pap specimen collection seems to be a sim-
ple, standardized procedure and most of the involved
clinicians had been educated, the quality of the specimen
Table I. Abnormal Findings in Reprocessed Specimens and
the General Population
Category HSIL ASCUS AGC Overall
Reprocessed 0.78% 10.08% 2.33% 13.18%
General 0.36% 3.62% 0.11% 6.91%
P-value 0.9583 0.0003 <0.0001 0.0088
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is after all operator-dependent. Review of the specimen
collecting techniques among the small number of collec-
tors who generated unsatisfactory Pap test specimens may
be a useful approach to reduce the number of unsatisfac-
tory specimens.
Obscuration by blood and its consequence of too few
squamous cells are among the major causes of unsatisfac-
tory. Bentz et al. demonstrated that coexisting red blood
cells compete with squamous cells to be retrieved on the
filter that transfer the cells to the slides.11 Our observation
of ThinPrep device filters with specimens provided direct
visual evidence that intact RBC interfere with the process-
ing of ThinPrep specimen through clogging the pores of
the ThinPrep device filter. The pore size of the filter is
estimated about 10 mm in diameter, approximate the di-
ameter of the red and white blood cells. If the pore size is
enlarged to a size that allows RBC to pass, the interfer-
ence may be reduced.
In summary, reprocessing unsatisfactory ThinPrep
specimens that contain microscopic red blood cells is a
practical and cost-effective procedure, resulting in signifi-
cant reduction of unsatisfactory rate. A patient with such
a specimen is at higher risk of harboring a cervical lesion.
Post menopausal status and the specimen collecting day
close to LMP may be causes for the unsatisfactory speci-
men. Further education to the specimen collectors may
improve the quality of specimen.
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